Leukotriene receptor antagonist, montelukast ameliorates l-name-induced pre-eclampsia in rats through suppressing the il-6/jak2/stat3 signaling pathway

HIGHLIGHTS

• who: Walaa Yehia Abdelzaher and colleagues from the Department of Pharmacology, Faculty of Medicine, Minia University, Minia, EgyptPharmacology Department, Medical College, Jouf University, Sakaka, Saudi Arabia have published the research work: Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway, in the Journal: Pharmaceuticals 2022, 914 of /2022/
• what: In athe work, L-NAME, nitric oxide (NOS) PE-like inhibitor, was used to induce PEcurrent rat model, which is wella proven to besynthase able to imitate manifestations induce a PE rat model, which . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.